Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 9 Results

Title
Intervention Indication Therapeutic Area Year Actions
Abrocitinib for moderate to severe atopic dermatitis Abrocitinib (PF-04965842) Atopic dermatitis Dermatology 2020 View  |  Download
Baricitinib for moderate to severe atopic dermatitis Baricitinib (LY3009104; Olumiant) , Corticosteroids Atopic dermatitis Dermatology 2019 View  |  Download
Baricitinib for treating atopic dermatitis in children and adolescents Baricitinib (LY3009104; Olumiant) Atopic dermatitis Dermatology 2022 View  |  Download
Dupilumab for Children Aged 12 Years to 17 Years with Moderate to Severe Atopic Dermatitis Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Atopic dermatitis Dermatology 2018 View  |  Download
Dupilumab for children aged 6 to less than 12 years with severe atopic dermatitis Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Atopic dermatitis Dermatology 2019 View  |  Download
Lebrikizumab for moderate to severe atopic dermatitis Lebrikizumab (TNX-650; LY3650150) Atopic dermatitis Dermatology 2021 View  |  Download
Tralokinumab for adolescents with moderate to severe atopic dermatitis Tralokinumab (CAT-354; LP 0162) Atopic dermatitis Dermatology 2020 View  |  Download
Tralokinumab for atopic dermatitis Tralokinumab (CAT-354; LP 0162) Atopic dermatitis Dermatology 2019 View  |  Download
Upadacitinib for atopic dermatitis Upadacitinib (ABT-494; Rinvoq; upadacitinib hemihydrate) Atopic dermatitis Dermatology 2019 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications